Hadi A Hamid A Selected Research

cycloartane

1/2020	Correction to: Cycloartane triterpenoid (23R, 24E)-23-acetoxymangiferonic acid inhibited proliferation and migration in B16-F10 melanoma via MITF downregulation caused by inhibition of both β-catenin and c-Raf-MEK1-ERK signaling axis.
1/2019	Cycloartane triterpenoid (23R, 24E)-23-acetoxymangiferonic acid inhibited proliferation and migration in B16-F10 melanoma via MITF downregulation caused by inhibition of both β-catenin and c-Raf-MEK1-ERK signaling axis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hadi A Hamid A Research Topics

Disease

2	Melanoma (Melanoma, Malignant) 01/2020 - 01/2019

Drug/Important Bio-Agent (IBA)

2	cycloartaneIBA 01/2020 - 01/2019
2	AcidsIBA 01/2020 - 01/2019
2	TriterpenesIBA 01/2020 - 01/2019
2	CateninsIBA 01/2020 - 01/2019
1	Monophenol Monooxygenase (Tyrosinase)IBA 01/2019
1	Methanol (Carbinol)IBA 01/2019
1	Biological ProductsIBA 01/2019
1	Melanins (Melanin)IBA 01/2019